Nutritional compositions with phospholipids
AssigneeNestec S.A.
InventorsKarl-Josef Huber-Haag, Catherine Mace, Phillippe Steenhout, Lien-Ahn Tran
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nutritional composition such as an infant formula comprising phospholipids in an amount of at least 300 mg/L. Bioactive compounds may preferably be added to the nutritional composition. The present invention also relates to use of said nutritional composition by feeding an infant with the nutritional composition for reducing the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.
Claims17
A nutritional composition comprising phospholipid in an amount of at least 300 mg/L.
A method for obtaining a lower C-peptide level in an infant as compared to the C-peptide level in an infant fed with a standard nutritional composition comprising the step of administering to an infant in need of same a nutritional composition comprising phospholipid in an amount of at least 300 mg/L.
A method for obtaining an insulin secretion in an infant approximating the insulin secretion in a breast fed infant comprising the step of administering to an infant in need of same a nutritional composition comprising phospholipid in an amount of at least 300 mg/L.
A method for reducing the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance and/or diabetes mellitus later in an infant's life comprising the step of administering to an infant in need of same a nutritional composition comprising phospholipid in an amount of at least 300 mg/L.
A method for reducing the risk of developing hyperinsulinemia and/or its insulin secretion and/or to reduce the risk of developing diseases associated thereof in an infant comprising the step of administering to an infant in need of same a nutritional composition comprising phospholipid in an amount of at least 300 mg/L.
(canceled)
Dependencies are inferred from the claim text.